<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.6378</article-id>
<article-id pub-id-type="publisher-id">mmr-15-05-3336</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The risk of HCV infection among health-care workers and its association with extrahepatic manifestations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Garozzo</surname><given-names>Adriana</given-names></name>
<xref rid="af1-mmr-15-05-3336" ref-type="aff">1</xref>
<xref rid="fn1-mmr-15-05-3336" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Falzone</surname><given-names>Luca</given-names></name>
<xref rid="af2-mmr-15-05-3336" ref-type="aff">2</xref>
<xref rid="fn1-mmr-15-05-3336" ref-type="author-notes">&#x002A;</xref></contrib>
<contrib contrib-type="author"><name><surname>Rapisarda</surname><given-names>Venerando</given-names></name>
<xref rid="af3-mmr-15-05-3336" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Marconi</surname><given-names>Andrea</given-names></name>
<xref rid="af3-mmr-15-05-3336" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Cin&#x00E0;</surname><given-names>Diana</given-names></name>
<xref rid="af4-mmr-15-05-3336" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Fenga</surname><given-names>Concettina</given-names></name>
<xref rid="af5-mmr-15-05-3336" ref-type="aff">5</xref></contrib>
<contrib contrib-type="author"><name><surname>Spandidos</surname><given-names>Demetrios A.</given-names></name>
<xref rid="af6-mmr-15-05-3336" ref-type="aff">6</xref></contrib>
<contrib contrib-type="author"><name><surname>Libra</surname><given-names>Massimo</given-names></name>
<xref rid="af2-mmr-15-05-3336" ref-type="aff">2</xref>
<xref rid="c1-mmr-15-05-3336" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-15-05-3336"><label>1</label>Section of Microbiology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95124 Catania, Italy</aff>
<aff id="af2-mmr-15-05-3336"><label>2</label>Section of General, Clinical and Oncological Pathology, Department of Biomedical and Biotechnological Sciences, University of Catania, I-95123 Catania, Italy</aff>
<aff id="af3-mmr-15-05-3336"><label>3</label>Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I-9124 Catania, Italy</aff>
<aff id="af4-mmr-15-05-3336"><label>4</label>Department of Clinical Pathology, Garibaldi Hospital, I-9124 Catania, Italy</aff>
<aff id="af5-mmr-15-05-3336"><label>5</label>Section of Occupational Medicine, Department of the Environment, Safety, Territory, Food and Health Sciences, University of Messina, I-98125 Messina, Italy</aff>
<aff id="af6-mmr-15-05-3336"><label>6</label>Department of Virology, Faculty of Medicine, University of Crete, Heraklion 71003, Crete, Greece</aff>
<author-notes>
<corresp id="c1-mmr-15-05-3336"><italic>Correspondence to</italic>: Dr Massimo Libra, Section of General, Clinical and Oncological Pathology, Department of Biomedical and Biotechnological Sciences, University of Catania, Torre Biologica, Via Santa Sofia 97, I-95123 Catania, Italy, E-mail: <email>m.libra@unict.it</email></corresp>
<fn id="fn1-mmr-15-05-3336"><label>&#x002A;</label><p>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="ppub"><month>05</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>24</day><month>03</month><year>2017</year></pub-date>
<volume>15</volume>
<issue>5</issue>
<fpage>3336</fpage>
<lpage>3339</lpage>
<history>
<date date-type="received"><day>05</day><month>01</month><year>2017</year></date>
<date date-type="accepted"><day>21</day><month>02</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Garozzo et al.</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Health care workers (HCWs) are frequently exposed to different biological agents during their activities and are frequently monitored. Among these infectious agents, human hepatitis C (HCV) can infect HCWs. In this review article, the risk of HCV infection among HCWs is discussed along with extrahepatic HCV-related malignancies, such as non-Hodgkin lymphoma. Accidental contamination, represented by percutaneous and mucocutaneous infections is the main risk factor for such infection. The compliance of the protection procedures, included in the current regulation for HCWs, is the most important issue to reduce the risk of pathogen infections that in turn may produce reduction of infection-associated malignancies.</p>
</abstract>
<kwd-group>
<kwd>health-care workers</kwd>
<kwd>human hepatitis C</kwd>
<kwd>biological risk</kwd>
<kwd>lymphoma</kwd>
<kwd>occupational exposure</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Many professional activities expose workers to several biological agents representing a consistent risk factor for the development of infective and non-infective pathologies. Among these activities, including different professional areas such as agriculture, breeding of livestock, food industry and biotechnology, the most dangerous biohazard is the health-care associated activity. Because of the intrinsic purpose of hospital workplace, health care workers (HCWs) may be exposed to biological agents. Accordingly, HCWs are frequently controlled and monitored because of the high risk of biological contamination during their activities (<xref rid="b1-mmr-15-05-3336" ref-type="bibr">1</xref>). It was assessed that the biological risk in workplaces is responsible for &#x003E;300,000 deaths per year worldwide underlining the importance of the development of new monitoring strategies and approaches to prevent the spread of contamination in indoor and closed workplaces, such as hospitals (<xref rid="b2-mmr-15-05-3336" ref-type="bibr">2</xref>).</p>
<p>One of the main sources of nosocomial biohazard contamination are the bio-aerosols containing a plethora of microorganisms, including endotoxins and molds, able to determine infections in both patients and HCWs through their inhalation (<xref rid="b3-mmr-15-05-3336" ref-type="bibr">3</xref>,<xref rid="b4-mmr-15-05-3336" ref-type="bibr">4</xref>). Another source of contamination, especially for viral infections, may occur by direct exposure to biological fluids, including blood, urine, semen and cerebral spinal fluid (<xref rid="b5-mmr-15-05-3336" ref-type="bibr">5</xref>). Unfortunately, this contamination is often linked to percutaneous transmission occurring after needle-stick injuries or cuts with other sharp instruments (<xref rid="b6-mmr-15-05-3336" ref-type="bibr">6</xref>).</p>
<p>Several microorganisms such as <italic>Pseudomonas aeruginosa</italic>, <italic>Pseudomonas spp</italic>, <italic>Staphylococcus aureus</italic>, <italic>Staphylococcus epidermidis</italic>, <italic>Acinetobacter</italic>, <italic>Enterobacter</italic>, <italic>Enterococcus</italic> and <italic>Legionella</italic> can infect HCWs in different hospital environments (<xref rid="b7-mmr-15-05-3336" ref-type="bibr">7</xref>,<xref rid="b8-mmr-15-05-3336" ref-type="bibr">8</xref>). The infections due to these bacteria are particularly difficult to eradicate because the infectious agent may acquire different mechanisms of resistance for which the use of the common antibiotic therapy is ineffective. One study has shown how in these cases the use of drugs such as netilmicin is able to reduce the adhesiveness, hydrophobic interactions, fimbriation or motility of the bacteria, although it is not able to kill them, thus reducing the risk of infections or the development of severe infectious diseases (<xref rid="b9-mmr-15-05-3336" ref-type="bibr">9</xref>).</p>
<p>HCWs can also be infected by several viruses. Many of these may cause neoplastic transformation and are recognized as &#x2018;carcinogenic to human (group 1) by the International Agency for Research on Cancer (IARC)&#x2019;. Among these, Epstein-Barr virus (EBV), hepatitis B and C viruses (HBV and HCV), human T-cell lymphotropic virus type 1 (HTLV-1), human herpes virus type 8 (HHV-8) and human papillomavirus (HPV) are the most common viruses responsible for cancer development after chronic infection (<xref rid="b10-mmr-15-05-3336" ref-type="bibr">10</xref>&#x2013;<xref rid="b17-mmr-15-05-3336" ref-type="bibr">17</xref>). The discovery of novel antiviral therapies, including that for HCV infection (<xref rid="b18-mmr-15-05-3336" ref-type="bibr">18</xref>), may reduce the development of many cancer types. Based on the above, our research group investigated the antiviral and antiproliferative effects of novel compounds belonging to the class of C-nucleosides showing encouraging results for the treatments of cancer, especially in the context of viral infections (<xref rid="b19-mmr-15-05-3336" ref-type="bibr">19</xref>).</p>
<p>Our previous studies described the frequency of HCV infection among HCWs and a case of non-Hodgkin lymphoma was diagnosed during the survey (<xref rid="b20-mmr-15-05-3336" ref-type="bibr">20</xref>,<xref rid="b21-mmr-15-05-3336" ref-type="bibr">21</xref>). According to this observation, in the present review, HCV infection among HCWs is analyzed taking into account the association with lymphoma development.</p>
</sec>
<sec>
<label>2.</label>
<title>HCV infection in health-care workers</title>
<p>Several studies show that a correct knowledge and training of health-care workers significantly reduces the risk of accidental exposure to biological agents. Notably, the frequency of accidental exposure to biohazard agents increases among workers with less working seniority, such as nursing students or trainees, compared to the older workers (<xref rid="b22-mmr-15-05-3336" ref-type="bibr">22</xref>&#x2013;<xref rid="b24-mmr-15-05-3336" ref-type="bibr">24</xref>). Conversely, other studies showed that workers with &#x003E;15 years professional experience had an incidence rate for accidental contamination three times higher than workers with a work experience &#x2264;5 years (<xref rid="b25-mmr-15-05-3336" ref-type="bibr">25</xref>). These data may be due to a more prolonged exposure to biological risk in workers with higher work experience and not to the inexperience of the workers (<xref rid="b26-mmr-15-05-3336" ref-type="bibr">26</xref>&#x2013;<xref rid="b28-mmr-15-05-3336" ref-type="bibr">28</xref>).</p>
<p>The most common mode of transmission of HBV and HCV, during health-care work activities, is due to percutaneous exposure and sharp injuries (<xref rid="b29-mmr-15-05-3336" ref-type="bibr">29</xref>&#x2013;<xref rid="b31-mmr-15-05-3336" ref-type="bibr">31</xref>). Of note, many HCV infected patients do not show severe clinical manifestations and do not reveal their infection status to HCWs. Accordingly, the accidental contact with the infected material was previously very common. In fact, the World Health Organization (WHO) stated that in the European area only the percutaneous exposure risk of HBV and HCV infections in the health-care workers is &#x003E;450,000 cases of which 340,000 for HBV virus and 149,000 for HCV (<xref rid="b31-mmr-15-05-3336" ref-type="bibr">31</xref>&#x2013;<xref rid="b33-mmr-15-05-3336" ref-type="bibr">33</xref>). According to the current regulation, caution by all HCWs have to be applied with the patients with and without any diagnosed infections.</p>
<p>Our research group conducted a 10-year observational study to determine the frequency of HCV infection among HCWs from a single institution. This study included a case series of 403 workers employed in various clinical areas. This study showed that the high prevalence of HCV infection was found in nurses (3&#x0025;) and physicians/surgeons (5&#x0025;) in comparison to the other health-care worker categories. An important result of the study was that in the 10-year survey there were no new infections by HCV in the monitored workers. This result stresses the concept that the correct handling procedures of hazardous biological materials and the use of personal protective equipment lead to a reduction or a total avoidance of the risk of infection due to biohazard materials (<xref rid="b20-mmr-15-05-3336" ref-type="bibr">20</xref>,<xref rid="b34-mmr-15-05-3336" ref-type="bibr">34</xref>). Therefore, these data are in agreement with previous studies demonstrating that the education of workers employed in hospitals or laboratories on the prevention of needle-stick accidents or sharp injuries is able to decrease needle-stick injuries (<xref rid="b35-mmr-15-05-3336" ref-type="bibr">35</xref>&#x2013;<xref rid="b37-mmr-15-05-3336" ref-type="bibr">37</xref>). The cross contamination occurred between infected patients and health-care workers and vice versa could be avoided wearing protective barriers (gloves and lab coat), washing hands frequently and taking care in using biological materials, needles or sharp objects. The use of written protocols and standard procedures is certainly a good strategy that allows to minimize the risk of accidental infection caused by HCV and other hazardous biological agents with which workers may come into contact in hospitals (<xref rid="b38-mmr-15-05-3336" ref-type="bibr">38</xref>,<xref rid="b39-mmr-15-05-3336" ref-type="bibr">39</xref>).</p>
</sec>
<sec>
<label>3.</label>
<title>HCV infection as a risk factor for lymphoma development</title>
<p>It is already known that HCV infection promotes hepatic (<xref rid="b40-mmr-15-05-3336" ref-type="bibr">40</xref>,<xref rid="b41-mmr-15-05-3336" ref-type="bibr">41</xref>) and extra-hepatic diseases including vascular and musculoskeletal disorders (e.g., cryoglobulinemia, arthralgia and myalgia), cardiovascular, renal, autoimmune and B-cell lymphoproliferative diseases (<xref rid="b42-mmr-15-05-3336" ref-type="bibr">42</xref>&#x2013;<xref rid="b49-mmr-15-05-3336" ref-type="bibr">49</xref>).</p>
<p>In our experience, the above mentioned 10-year study, revealed that one of the HCV-infected HCWs, with a chronic infection history of 25 years, developed a mucosa-associated lymphoid tissue lymphoma (MALT) of the liver (<xref rid="b20-mmr-15-05-3336" ref-type="bibr">20</xref>). Molecular analyses of tumor tissue indicated that immunoglobulin gene combinations were those usually detected among HCV-associated lymphomas (<xref rid="b11-mmr-15-05-3336" ref-type="bibr">11</xref>). Furthermore, the discovery of MALT lymphoma with the concomitant HCV infection prompted us to extend the investigation to a larger cohort of HCWs. Thus, a tailored health surveillance program to 3,138 health-care workers employed in four Italian medical institutions was applied (<xref rid="b21-mmr-15-05-3336" ref-type="bibr">21</xref>). Of these, 1,352 (43&#x0025;) were nurses, 953 (30&#x0025;) were physicians and surgeons and 833 (27&#x0025;) were other employees working in medical institutions. All the workers were screened for HCV infection by anti-HCV antibodies. HCV infection was detected in 229 out of 3,138 HCWs (7.3&#x0025;). Of the HCV-infected HCWs, 43&#x0025; were nurses, 34&#x0025; physician and surgeons and 23&#x0025; were other employees (<xref rid="f1-mmr-15-05-3336" ref-type="fig">Fig. 1</xref>). Intriguingly, a case of gastric Malt lymphoma was observed among those with HCV infection (<xref rid="b21-mmr-15-05-3336" ref-type="bibr">21</xref>). As revealed in the previous independent survey of HCWs by Marconi <italic>et al</italic>, 2010, the molecular analyses performed in such Malt tumor tissue supported the notion that HCV infection was associated with the malignant transformation (<xref rid="b20-mmr-15-05-3336" ref-type="bibr">20</xref>).</p>
</sec>
<sec sec-type="conclusions">
<label>4.</label>
<title>Conclusions</title>
<p>Health-care professionals are a working category particularly exposed to biological risk factors during the normal working activities. These workers are daily subjected to occupational biological exposure in handling blood-borne samples or other biological fluids. One of the main sources of accidental contamination is represented by percutaneous and mucocutaneous infections (<xref rid="b24-mmr-15-05-3336" ref-type="bibr">24</xref>). Microorganisms contained in aerosols, aerial dissemination caused by ventilation systems and direct infection with affected patients represent other ways of contamination (<xref rid="b50-mmr-15-05-3336" ref-type="bibr">50</xref>). The application of the standard precautions during work activities is the most important reason in reducing the risk of blood-borne pathogen transmission that in turn may result in reduction of infection-related cancers.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-mmr-15-05-3336"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messineo</surname><given-names>A</given-names></name><name><surname>Marsella</surname><given-names>LT</given-names></name></person-group><article-title>Biological hazards and healthcare-associated infections in Italian healthcare facilities: Some considerations on inspections and accountability</article-title><source>Ann Ig</source><volume>27</volume><fpage>799</fpage><lpage>807</lpage><year>2015</year><pub-id pub-id-type="pmid">26835794</pub-id></element-citation></ref>
<ref id="b2-mmr-15-05-3336"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrao</surname><given-names>CR</given-names></name><name><surname>Mazzotta</surname><given-names>A</given-names></name><name><surname>La Torre</surname><given-names>G</given-names></name><name><surname>De Giusti</surname><given-names>M</given-names></name></person-group><article-title>Biological risk and occupational health</article-title><source>Ind Health</source><volume>50</volume><fpage>326</fpage><lpage>337</lpage><year>2012</year><pub-id pub-id-type="doi">10.2486/indhealth.MS1324</pub-id><pub-id pub-id-type="pmid">22785422</pub-id></element-citation></ref>
<ref id="b3-mmr-15-05-3336"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srikanth</surname><given-names>P</given-names></name><name><surname>Sudharsanam</surname><given-names>S</given-names></name><name><surname>Steinberg</surname><given-names>R</given-names></name></person-group><article-title>Bio-aerosols in indoor environment: Composition, health effects and analysis</article-title><source>Indian J Med Microbiol</source><volume>26</volume><fpage>302</fpage><lpage>312</lpage><year>2008</year><pub-id pub-id-type="doi">10.4103/0255-0857.43555</pub-id><pub-id pub-id-type="pmid">18974481</pub-id></element-citation></ref>
<ref id="b4-mmr-15-05-3336"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heimbuch</surname><given-names>BK</given-names></name><name><surname>Wallace</surname><given-names>WH</given-names></name><name><surname>Balzli</surname><given-names>CL</given-names></name><name><surname>Laning</surname><given-names>ML</given-names></name><name><surname>Harnish</surname><given-names>DA</given-names></name><name><surname>Wander</surname><given-names>JD</given-names></name></person-group><article-title>Bioaerosol exposure to personnel in a clinical environment absent patients</article-title><source>J Occup Environ Hyg</source><volume>13</volume><fpage>D11</fpage><lpage>D15</lpage><year>2016</year><pub-id pub-id-type="doi">10.1080/15459624.2015.1091966</pub-id><pub-id pub-id-type="pmid">26375496</pub-id></element-citation></ref>
<ref id="b5-mmr-15-05-3336"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarantola</surname><given-names>A</given-names></name><name><surname>Abiteboul</surname><given-names>D</given-names></name><name><surname>Rachline</surname><given-names>A</given-names></name></person-group><article-title>Infection risks following accidental exposure to blood or body fluids in health care workers: A review of pathogens transmitted in published cases</article-title><source>Am J Infect Control</source><volume>34</volume><fpage>367</fpage><lpage>375</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.ajic.2004.11.011</pub-id><pub-id pub-id-type="pmid">16877106</pub-id></element-citation></ref>
<ref id="b6-mmr-15-05-3336"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castella</surname><given-names>A</given-names></name><name><surname>Vallino</surname><given-names>A</given-names></name><name><surname>Argentero</surname><given-names>PA</given-names></name><name><surname>Zotti</surname><given-names>CM</given-names></name></person-group><article-title>Preventability of percutaneous injuries in healthcare workers: A year-long survey in Italy</article-title><source>J Hosp Infect</source><volume>55</volume><fpage>290</fpage><lpage>294</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/j.jhin.2003.08.013</pub-id><pub-id pub-id-type="pmid">14629973</pub-id></element-citation></ref>
<ref id="b7-mmr-15-05-3336"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierce</surname><given-names>GE</given-names></name></person-group><article-title><italic>Pseudomonas aeruginosa</italic>, <italic>Candida albicans</italic>, and device-related nosocomial infections: Implications, trends, and potential approaches for control</article-title><source>J Ind Microbiol Biotechnol</source><volume>32</volume><fpage>309</fpage><lpage>318</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/s10295-005-0225-2</pub-id><pub-id pub-id-type="pmid">15868157</pub-id></element-citation></ref>
<ref id="b8-mmr-15-05-3336"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beggs</surname><given-names>CB</given-names></name><name><surname>Kerr</surname><given-names>KG</given-names></name><name><surname>Noakes</surname><given-names>CJ</given-names></name><name><surname>Hathway</surname><given-names>EA</given-names></name><name><surname>Sleigh</surname><given-names>PA</given-names></name></person-group><article-title>The ventilation of multiple-bed hospital wards: Review and analysis</article-title><source>Am J Infect Control</source><volume>36</volume><fpage>250</fpage><lpage>259</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.ajic.2007.07.012</pub-id><pub-id pub-id-type="pmid">18455045</pub-id></element-citation></ref>
<ref id="b9-mmr-15-05-3336"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furneri</surname><given-names>PM</given-names></name><name><surname>Garozzo</surname><given-names>A</given-names></name><name><surname>Musumarra</surname><given-names>MP</given-names></name><name><surname>Scuderi</surname><given-names>AC</given-names></name><name><surname>Russo</surname><given-names>A</given-names></name><name><surname>Bonfiglio</surname><given-names>G</given-names></name></person-group><article-title>Effects on adhesiveness and hydrophobicity of sub-inhibitory concentrations of netilmicin</article-title><source>Int J Antimicrob Agents</source><volume>22</volume><fpage>164</fpage><lpage>167</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0924-8579(03)00149-3</pub-id><pub-id pub-id-type="pmid">12927958</pub-id></element-citation></ref>
<ref id="b10-mmr-15-05-3336"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinozaki-Ushiku</surname><given-names>A</given-names></name><name><surname>Kunita</surname><given-names>A</given-names></name><name><surname>Fukayama</surname><given-names>M</given-names></name></person-group><article-title>Update on Epstein-Barr virus and gastric cancer (Review)</article-title><source>Int J Oncol</source><volume>46</volume><fpage>1421</fpage><lpage>1434</lpage><year>2015</year><pub-id pub-id-type="pmid">25633561</pub-id></element-citation></ref>
<ref id="b11-mmr-15-05-3336"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Gloghini</surname><given-names>A</given-names></name><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Rupolo</surname><given-names>M</given-names></name><name><surname>Navolanic</surname><given-names>PM</given-names></name><name><surname>Gasparotto</surname><given-names>D</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Spina</surname><given-names>M</given-names></name><name><surname>Boiocchi</surname><given-names>M</given-names></name><name><surname>Carbone</surname><given-names>A</given-names></name></person-group><article-title>Aggressive forms of non-Hodgkins lymphoma in two patients bearing coinfection of Epstein-Barr and hepatitis C viruses</article-title><source>Int J Oncol</source><volume>26</volume><fpage>945</fpage><lpage>950</lpage><year>2005</year><pub-id pub-id-type="pmid">15753988</pub-id></element-citation></ref>
<ref id="b12-mmr-15-05-3336"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gloghini</surname><given-names>A</given-names></name><name><surname>Gaidano</surname><given-names>G</given-names></name><name><surname>Larocca</surname><given-names>LM</given-names></name><name><surname>Pierconti</surname><given-names>F</given-names></name><name><surname>Cingolani</surname><given-names>A</given-names></name><name><surname>Dal Maso</surname><given-names>L</given-names></name><name><surname>Capello</surname><given-names>D</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Tirelli</surname><given-names>U</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><etal/></person-group><article-title>Expression of cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1</article-title><source>Am J Pathol</source><volume>161</volume><fpage>163</fpage><lpage>171</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64168-5</pub-id><pub-id pub-id-type="pmid">12107101</pub-id><pub-id pub-id-type="pmcid">1850708</pub-id></element-citation></ref>
<ref id="b13-mmr-15-05-3336"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arzumanyan</surname><given-names>A</given-names></name><name><surname>Reis</surname><given-names>HM</given-names></name><name><surname>Feitelson</surname><given-names>MA</given-names></name></person-group><article-title>Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma</article-title><source>Nat Rev Cancer</source><volume>13</volume><fpage>123</fpage><lpage>135</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nrc3449</pub-id><pub-id pub-id-type="pmid">23344543</pub-id></element-citation></ref>
<ref id="b14-mmr-15-05-3336"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Caggiari</surname><given-names>L</given-names></name><name><surname>De Zorzi</surname><given-names>M</given-names></name><name><surname>Repetto</surname><given-names>O</given-names></name><name><surname>Zignego</surname><given-names>AL</given-names></name><name><surname>Izzo</surname><given-names>F</given-names></name><name><surname>Tornesello</surname><given-names>ML</given-names></name><name><surname>Buonaguro</surname><given-names>FM</given-names></name><name><surname>Mangia</surname><given-names>A</given-names></name><name><surname>Sansonno</surname><given-names>D</given-names></name><etal/></person-group><article-title>Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases</article-title><source>PLoS One</source><volume>10</volume><fpage>e0117420</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0128849</pub-id><pub-id pub-id-type="pmid">25700262</pub-id><pub-id pub-id-type="pmcid">4336327</pub-id></element-citation></ref>
<ref id="b15-mmr-15-05-3336"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beral</surname><given-names>V</given-names></name><name><surname>Peterman</surname><given-names>T</given-names></name><name><surname>Berkelman</surname><given-names>R</given-names></name><name><surname>Jaffe</surname><given-names>H</given-names></name></person-group><article-title>AIDS-associated non-Hodgkin lymphoma</article-title><source>Lancet</source><volume>337</volume><fpage>805</fpage><lpage>809</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0140-6736(91)92513-2</pub-id><pub-id pub-id-type="pmid">1672911</pub-id></element-citation></ref>
<ref id="b16-mmr-15-05-3336"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Scalisi</surname><given-names>A</given-names></name><name><surname>Vella</surname><given-names>N</given-names></name><name><surname>Clementi</surname><given-names>S</given-names></name><name><surname>Sorio</surname><given-names>R</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Mazzarino</surname><given-names>C</given-names></name></person-group><article-title>Uterine cervical carcinoma: Role of matrix metalloproteinases (Review)</article-title><source>Int J Oncol</source><volume>34</volume><fpage>897</fpage><lpage>903</lpage><year>2009</year><pub-id pub-id-type="doi">10.3892/ijo_00000215</pub-id><pub-id pub-id-type="pmid">19287946</pub-id></element-citation></ref>
<ref id="b17-mmr-15-05-3336"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petry</surname><given-names>KU</given-names></name></person-group><article-title>HPV and cervical cancer</article-title><source>Scand J Clin Lab Invest Suppl</source><volume>244</volume><fpage>59</fpage><lpage>62</lpage><year>2014</year><pub-id pub-id-type="doi">10.3109/00365513.2014.936683</pub-id><pub-id pub-id-type="pmid">25083895</pub-id></element-citation></ref>
<ref id="b18-mmr-15-05-3336"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewers</surname><given-names>EC</given-names></name><name><surname>Shah</surname><given-names>PA</given-names></name><name><surname>Carmichael</surname><given-names>MG</given-names></name><name><surname>Ferguson</surname><given-names>TM</given-names></name></person-group><article-title>Concurrent systemic chemoimmunotherapy and sofosbuvir-based antiviral treatment in a hepatitis C virus-infected patient with diffuse large B-cell lymphoma</article-title><source>Open Forum Infect Dis</source><volume>3</volume><fpage>ofw223</fpage><year>2016</year><pub-id pub-id-type="doi">10.1093/ofid/ofw223</pub-id><pub-id pub-id-type="pmid">28018926</pub-id><pub-id pub-id-type="pmcid">5170491</pub-id></element-citation></ref>
<ref id="b19-mmr-15-05-3336"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giofr&#x00E8;</surname><given-names>SV</given-names></name><name><surname>Romeo</surname><given-names>R</given-names></name><name><surname>Carnovale</surname><given-names>C</given-names></name><name><surname>Mancuso</surname><given-names>R</given-names></name><name><surname>Cirmi</surname><given-names>S</given-names></name><name><surname>Navarra</surname><given-names>M</given-names></name><name><surname>Garozzo</surname><given-names>A</given-names></name><name><surname>Chiacchio</surname><given-names>MA</given-names></name></person-group><article-title>Synthesis and biological properties of 5-(1<italic>H</italic>-1,2,3-triazol-4-yl)isoxazolidines: A new class of <italic>C</italic>-nucleosides</article-title><source>Molecules</source><volume>20</volume><fpage>5260</fpage><lpage>5275</lpage><year>2015</year><pub-id pub-id-type="doi">10.3390/molecules20045260</pub-id><pub-id pub-id-type="pmid">25812148</pub-id></element-citation></ref>
<ref id="b20-mmr-15-05-3336"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Candido</surname><given-names>S</given-names></name><name><surname>Talamini</surname><given-names>R</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Nicoletti</surname><given-names>F</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Proietti</surname><given-names>L</given-names></name></person-group><article-title>Prevalence of hepatitis C virus infection among health-care workers: A 10-year survey</article-title><source>Mol Med Rep</source><volume>3</volume><fpage>561</fpage><lpage>564</lpage><year>2010</year><pub-id pub-id-type="pmid">21472279</pub-id></element-citation></ref>
<ref id="b21-mmr-15-05-3336"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapisarda</surname><given-names>V</given-names></name><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Candido</surname><given-names>S</given-names></name><name><surname>Nicolosi</surname><given-names>D</given-names></name><name><surname>Salmeri</surname><given-names>M</given-names></name><name><surname>Gangemi</surname><given-names>P</given-names></name><name><surname>Proietti</surname><given-names>L</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Bracci</surname><given-names>M</given-names></name><name><surname>Fenga</surname><given-names>C</given-names></name><etal/></person-group><article-title>A tailored health surveillance program unveils a case of MALT lymphoma in an HCV-positive health-care worker</article-title><source>Oncol Lett</source><volume>5</volume><fpage>651</fpage><lpage>654</lpage><year>2013</year><pub-id pub-id-type="pmid">23420489</pub-id></element-citation></ref>
<ref id="b22-mmr-15-05-3336"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maniar</surname><given-names>HH</given-names></name><name><surname>Tawari</surname><given-names>AA</given-names></name><name><surname>Suk</surname><given-names>M</given-names></name><name><surname>Bowen</surname><given-names>TR</given-names></name><name><surname>Horwitz</surname><given-names>DS</given-names></name></person-group><article-title>Percutaneous and mucocutaneous exposure among orthopaedic surgeons: Immediate management and compliance with CDC protocol</article-title><source>J Orthop Trauma</source><volume>29</volume><fpage>e391</fpage><lpage>e394</lpage><year>2015</year><pub-id pub-id-type="doi">10.1097/BOT.0000000000000360</pub-id><pub-id pub-id-type="pmid">25967855</pub-id></element-citation></ref>
<ref id="b23-mmr-15-05-3336"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>N</given-names></name><name><surname>Allami</surname><given-names>A</given-names></name><name><surname>Mohamadi</surname><given-names>Malek R</given-names></name></person-group><article-title>Percutaneous exposure incidents in nurses: Knowledge, practice and exposure to hepatitis B infection: Percutaneous exposure incidents in nurses</article-title><source>Hepat Mon</source><volume>11</volume><fpage>186</fpage><lpage>190</lpage><year>2011</year><pub-id pub-id-type="pmid">22087141</pub-id><pub-id pub-id-type="pmcid">3206680</pub-id></element-citation></ref>
<ref id="b24-mmr-15-05-3336"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrucci</surname><given-names>C</given-names></name><name><surname>Alvaro</surname><given-names>R</given-names></name><name><surname>Cicolini</surname><given-names>G</given-names></name><name><surname>Cerone</surname><given-names>MP</given-names></name><name><surname>Lancia</surname><given-names>L</given-names></name></person-group><article-title>Percutaneous and mucocutaneous exposures in nursing students: An Italian observational study</article-title><source>J Nurs Scholarsh</source><volume>41</volume><fpage>337</fpage><lpage>343</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1547-5069.2009.01301.x</pub-id><pub-id pub-id-type="pmid">19941578</pub-id></element-citation></ref>
<ref id="b25-mmr-15-05-3336"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosgeroglu</surname><given-names>N</given-names></name><name><surname>Ayranci</surname><given-names>U</given-names></name><name><surname>Vardareli</surname><given-names>E</given-names></name><name><surname>Dincer</surname><given-names>S</given-names></name></person-group><article-title>Occupational exposure to hepatitis infection among Turkish nurses: Frequency of needle exposure, sharps injuries and vaccination</article-title><source>Epidemiol Infect</source><volume>132</volume><fpage>27</fpage><lpage>33</lpage><year>2004</year><pub-id pub-id-type="doi">10.1017/S0950268803001407</pub-id><pub-id pub-id-type="pmid">14979586</pub-id><pub-id pub-id-type="pmcid">2870074</pub-id></element-citation></ref>
<ref id="b26-mmr-15-05-3336"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alese</surname><given-names>OO</given-names></name><name><surname>Alese</surname><given-names>MO</given-names></name><name><surname>Ohunakin</surname><given-names>A</given-names></name><name><surname>Oluyide</surname><given-names>PO</given-names></name></person-group><article-title>Seroprevalence of hepatitis B surface antigen and occupational risk factors among health care workers in Ekiti State, Nigeria</article-title><source>J Clin Diagn Res</source><volume>10</volume><fpage>LC16</fpage><lpage>LC18</lpage><year>2016</year><pub-id pub-id-type="pmid">27042489</pub-id><pub-id pub-id-type="pmcid">4800554</pub-id></element-citation></ref>
<ref id="b27-mmr-15-05-3336"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarakul</surname><given-names>S</given-names></name><name><surname>Eunumjitkul</surname><given-names>K</given-names></name><name><surname>Vuttiopas</surname><given-names>S</given-names></name><name><surname>Vorapimol</surname><given-names>AR</given-names></name><name><surname>Kaewkungwal</surname><given-names>J</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name></person-group><article-title>Seroprevalence and risk factors of hepatitis B virus infection among health care workers at the Institute of Neurology</article-title><source>J Med Assoc Thai</source><volume>90</volume><fpage>1536</fpage><lpage>1545</lpage><year>2007</year><pub-id pub-id-type="pmid">17926982</pub-id></element-citation></ref>
<ref id="b28-mmr-15-05-3336"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciorlia</surname><given-names>LA</given-names></name><name><surname>Zanetta</surname><given-names>DM</given-names></name></person-group><article-title>Hepatitis B in healthcare workers: Prevalence, vaccination and relation to occupational factors</article-title><source>Braz J Infect Dis</source><volume>9</volume><fpage>384</fpage><lpage>389</lpage><year>2005</year><pub-id pub-id-type="doi">10.1590/S1413-86702005000500005</pub-id><pub-id pub-id-type="pmid">16410889</pub-id></element-citation></ref>
<ref id="b29-mmr-15-05-3336"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mischke</surname><given-names>C</given-names></name><name><surname>Verbeek</surname><given-names>JH</given-names></name><name><surname>Saarto</surname><given-names>A</given-names></name><name><surname>Lavoie</surname><given-names>MC</given-names></name><name><surname>Pahwa</surname><given-names>M</given-names></name><name><surname>Ijaz</surname><given-names>S</given-names></name></person-group><article-title>Gloves, extra gloves or special types of gloves for preventing percutaneous exposure injuries in healthcare personnel</article-title><source>Cochrane Database Syst Rev</source><volume>3</volume><fpage>CD009573</fpage><year>2014</year></element-citation></ref>
<ref id="b30-mmr-15-05-3336"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbaisi</surname><given-names>EM</given-names></name><name><surname>Nganga</surname><given-names>Z</given-names></name><name><surname>Wanzala</surname><given-names>P</given-names></name><name><surname>Omolo</surname><given-names>J</given-names></name></person-group><article-title>Prevalence and factors associated with percutaneous injuries and splash exposures among health-care workers in a provincial hospital, Kenya, 2010</article-title><source>Pan Afr Med J</source><volume>14</volume><fpage>10</fpage><year>2013</year><pub-id pub-id-type="doi">10.11604/pamj.2013.14.10.1373</pub-id><pub-id pub-id-type="pmid">23504245</pub-id><pub-id pub-id-type="pmcid">3597860</pub-id></element-citation></ref>
<ref id="b31-mmr-15-05-3336"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pr&#x00FC;ss-Ust&#x00FC;n</surname><given-names>A</given-names></name><name><surname>Rapiti</surname><given-names>E</given-names></name><name><surname>Hutin</surname><given-names>Y</given-names></name></person-group><article-title>Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers</article-title><source>Am J Ind Med</source><volume>48</volume><fpage>482</fpage><lpage>490</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/ajim.20230</pub-id><pub-id pub-id-type="pmid">16299710</pub-id></element-citation></ref>
<ref id="b32-mmr-15-05-3336"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westermann</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>C</given-names></name><name><surname>Lisiak</surname><given-names>B</given-names></name><name><surname>Lamberti</surname><given-names>M</given-names></name><name><surname>Nienhaus</surname><given-names>A</given-names></name></person-group><article-title>The prevalence of hepatitis C among healthcare workers: A systematic review and meta-analysis</article-title><source>Occup Environ Med</source><volume>72</volume><fpage>880</fpage><lpage>888</lpage><year>2015</year><pub-id pub-id-type="doi">10.1136/oemed-2015-102879</pub-id><pub-id pub-id-type="pmid">26438666</pub-id><pub-id pub-id-type="pmcid">4680146</pub-id></element-citation></ref>
<ref id="b33-mmr-15-05-3336"><label>33</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pr&#x00FC;ss-Ust&#x00FC;n</surname><given-names>A</given-names></name><name><surname>Rapiti</surname><given-names>E</given-names></name><name><surname>Hutin</surname><given-names>Y</given-names></name></person-group><chapter-title>Sharp injuries: Global burden of disease from sharp injuries to health-care workers</chapter-title><source>Environmental Burden of Disease Series</source><comment>No. 3</comment><person-group person-group-type="editor"><name><surname>Pr&#x00FC;ss-&#x00DC;st&#x00FC;n</surname><given-names>A</given-names></name><name><surname>Campbell-Lendrum</surname><given-names>D</given-names></name><name><surname>Corval&#x00E1;n</surname><given-names>C</given-names></name><name><surname>Woodward</surname><given-names>A</given-names></name></person-group><publisher-name>World Health Organisation</publisher-name><publisher-loc>Geneva</publisher-loc><year>2003</year></element-citation></ref>
<ref id="b34-mmr-15-05-3336"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proietti</surname><given-names>L</given-names></name><name><surname>Malaponte</surname><given-names>G</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Navolanic</surname><given-names>PM</given-names></name><name><surname>Bevelacqua</surname><given-names>Y</given-names></name><name><surname>Travali</surname><given-names>S</given-names></name><name><surname>Mazzarino</surname><given-names>MC</given-names></name></person-group><article-title>Analysis of hepatitis C virus infection among health-care workers: An observational study</article-title><source>Minerva Gastroenterol Dietol</source><volume>51</volume><fpage>255</fpage><lpage>259</lpage><year>2005</year><pub-id pub-id-type="pmid">16280967</pub-id></element-citation></ref>
<ref id="b35-mmr-15-05-3336"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haiduven</surname><given-names>DJ</given-names></name><name><surname>Phillips</surname><given-names>ES</given-names></name><name><surname>Clemons</surname><given-names>KV</given-names></name><name><surname>Stevens</surname><given-names>DA</given-names></name></person-group><article-title>Percutaneous injury analysis: Consistent categorization, effective reduction methods, and future strategies</article-title><source>Infect Control Hosp Epidemiol</source><volume>16</volume><fpage>582</fpage><lpage>589</lpage><year>1995</year><pub-id pub-id-type="doi">10.1086/647012</pub-id><pub-id pub-id-type="pmid">8568203</pub-id></element-citation></ref>
<ref id="b36-mmr-15-05-3336"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarigan</surname><given-names>LH</given-names></name><name><surname>Cifuentes</surname><given-names>M</given-names></name><name><surname>Quinn</surname><given-names>M</given-names></name><name><surname>Kriebel</surname><given-names>D</given-names></name></person-group><article-title>Prevention of needle-stick injuries in healthcare facilities: A meta-analysis</article-title><source>Infect Control Hosp Epidemiol</source><volume>36</volume><fpage>823</fpage><lpage>829</lpage><year>2015</year><pub-id pub-id-type="doi">10.1017/ice.2015.50</pub-id><pub-id pub-id-type="pmid">25765502</pub-id></element-citation></ref>
<ref id="b37-mmr-15-05-3336"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Carli</surname><given-names>G</given-names></name><name><surname>Abiteboul</surname><given-names>D</given-names></name><name><surname>Puro</surname><given-names>V</given-names></name></person-group><article-title>The importance of implementing safe sharps practices in the laboratory setting in Europe</article-title><source>Biochem Med (Zagreb)</source><volume>24</volume><fpage>45</fpage><lpage>56</lpage><year>2014</year><pub-id pub-id-type="doi">10.11613/BM.2014.007</pub-id><pub-id pub-id-type="pmid">24627714</pub-id><pub-id pub-id-type="pmcid">3936965</pub-id></element-citation></ref>
<ref id="b38-mmr-15-05-3336"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davanzo</surname><given-names>E</given-names></name><name><surname>Frasson</surname><given-names>C</given-names></name><name><surname>Morandin</surname><given-names>M</given-names></name><name><surname>Trevisan</surname><given-names>A</given-names></name></person-group><article-title>Occupational blood and body fluid exposure of university health care workers</article-title><source>Am J Infect Control</source><volume>36</volume><fpage>753</fpage><lpage>756</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.ajic.2008.04.254</pub-id><pub-id pub-id-type="pmid">18945522</pub-id></element-citation></ref>
<ref id="b39-mmr-15-05-3336"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Gemert-Pijnen</surname><given-names>J</given-names></name><name><surname>Hendrix</surname><given-names>MG</given-names></name><name><surname>Van der Palen</surname><given-names>J</given-names></name><name><surname>Schellens</surname><given-names>PJ</given-names></name></person-group><article-title>Effectiveness of protocols for preventing occupational exposure to blood and body fluids in Dutch hospitals</article-title><source>J Hosp Infect</source><volume>62</volume><fpage>166</fpage><lpage>173</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.jhin.2005.07.010</pub-id><pub-id pub-id-type="pmid">16257086</pub-id></element-citation></ref>
<ref id="b40-mmr-15-05-3336"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denniston</surname><given-names>MM</given-names></name><name><surname>Jiles</surname><given-names>RB</given-names></name><name><surname>Drobeniuc</surname><given-names>J</given-names></name><name><surname>Klevens</surname><given-names>RM</given-names></name><name><surname>Ward</surname><given-names>JW</given-names></name><name><surname>McQuillan</surname><given-names>GM</given-names></name><name><surname>Holmberg</surname><given-names>SD</given-names></name></person-group><article-title>Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010</article-title><source>Ann Intern Med</source><volume>160</volume><fpage>293</fpage><lpage>300</lpage><year>2014</year><pub-id pub-id-type="doi">10.7326/M13-1133</pub-id><pub-id pub-id-type="pmid">24737271</pub-id><pub-id pub-id-type="pmcid">4562398</pub-id></element-citation></ref>
<ref id="b41-mmr-15-05-3336"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartosch</surname><given-names>B</given-names></name><name><surname>Thimme</surname><given-names>R</given-names></name><name><surname>Blum</surname><given-names>HE</given-names></name><name><surname>Zoulim</surname><given-names>F</given-names></name></person-group><article-title>Hepatitis C virus-induced hepatocarcinogenesis</article-title><source>J Hepatol</source><volume>51</volume><fpage>810</fpage><lpage>820</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.jhep.2009.05.008</pub-id><pub-id pub-id-type="pmid">19545926</pub-id></element-citation></ref>
<ref id="b42-mmr-15-05-3336"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taborelli</surname><given-names>M</given-names></name><name><surname>Polesel</surname><given-names>J</given-names></name><name><surname>Montella</surname><given-names>M</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Tedeschi</surname><given-names>R</given-names></name><name><surname>Battiston</surname><given-names>M</given-names></name><name><surname>Spina</surname><given-names>M</given-names></name><name><surname>Di Raimondo</surname><given-names>F</given-names></name><name><surname>Pinto</surname><given-names>A</given-names></name><name><surname>Crispo</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: A case-control study in Italy</article-title><source>Infect Agent Cancer</source><volume>11</volume><fpage>27</fpage><year>2016</year><pub-id pub-id-type="doi">10.1186/s13027-016-0073-x</pub-id><pub-id pub-id-type="pmid">27340429</pub-id><pub-id pub-id-type="pmcid">4918100</pub-id></element-citation></ref>
<ref id="b43-mmr-15-05-3336"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacoub</surname><given-names>P</given-names></name><name><surname>Commarmond</surname><given-names>C</given-names></name><name><surname>Sadoun</surname><given-names>D</given-names></name><name><surname>Desbois</surname><given-names>AC</given-names></name></person-group><article-title>Hepatitis C virus infection and rheumatic diseases: The impact of direct-acting antiviral agents</article-title><source>Rheum Dis Clin North Am</source><volume>43</volume><fpage>123</fpage><lpage>132</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.rdc.2016.09.011</pub-id><pub-id pub-id-type="pmid">27890169</pub-id></element-citation></ref>
<ref id="b44-mmr-15-05-3336"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacoub</surname><given-names>P</given-names></name><name><surname>Comarmond</surname><given-names>C</given-names></name><name><surname>Domont</surname><given-names>F</given-names></name><name><surname>Savey</surname><given-names>L</given-names></name><name><surname>Desbois</surname><given-names>AC</given-names></name><name><surname>Saadoun</surname><given-names>D</given-names></name></person-group><article-title>Extrahepatic manifestations of chronic hepatitis C virus infection</article-title><source>Ther Adv Infect Dis</source><volume>3</volume><fpage>3</fpage><lpage>14</lpage><year>2016</year><pub-id pub-id-type="doi">10.1177/2049936115585942</pub-id><pub-id pub-id-type="pmid">26862398</pub-id><pub-id pub-id-type="pmcid">4735500</pub-id></element-citation></ref>
<ref id="b45-mmr-15-05-3336"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrier</surname><given-names>B</given-names></name><name><surname>Cacoub</surname><given-names>P</given-names></name></person-group><article-title>Renal involvement in HCV-related vasculitis</article-title><source>Clin Res Hepatol Gastroenterol</source><volume>37</volume><fpage>334</fpage><lpage>339</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.clinre.2013.02.002</pub-id><pub-id pub-id-type="pmid">23562337</pub-id></element-citation></ref>
<ref id="b46-mmr-15-05-3336"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aslam</surname><given-names>F</given-names></name><name><surname>Alam</surname><given-names>M</given-names></name><name><surname>Lakkis</surname><given-names>NM</given-names></name></person-group><article-title>Hepatitis C and carotid atherosclerosis: A retrospective analysis</article-title><source>Atherosclerosis</source><volume>209</volume><fpage>340</fpage><lpage>343</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2009.10.006</pub-id><pub-id pub-id-type="pmid">19883912</pub-id></element-citation></ref>
<ref id="b47-mmr-15-05-3336"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Polesel</surname><given-names>J</given-names></name><name><surname>Russo</surname><given-names>AE</given-names></name><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Cin&#x00E0;</surname><given-names>D</given-names></name><name><surname>Serraino</surname><given-names>D</given-names></name><name><surname>Nicoletti</surname><given-names>F</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Talamini</surname><given-names>R</given-names></name></person-group><article-title>Extrahepatic disorders of HCV infection: A distinct entity of B-cell neoplasia?</article-title><source>Int J Oncol</source><volume>36</volume><fpage>1331</fpage><lpage>1340</lpage><year>2010</year><pub-id pub-id-type="doi">10.3892/ijo_00000618</pub-id><pub-id pub-id-type="pmid">20428756</pub-id></element-citation></ref>
<ref id="b48-mmr-15-05-3336"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Gloghini</surname><given-names>A</given-names></name><name><surname>Malaponte</surname><given-names>G</given-names></name><name><surname>Gangemi</surname><given-names>P</given-names></name><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Cacopardo</surname><given-names>B</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Nicoletti</surname><given-names>F</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Zignego</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas</article-title><source>J Hepatol</source><volume>49</volume><fpage>170</fpage><lpage>174</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.jhep.2008.03.031</pub-id><pub-id pub-id-type="pmid">18538438</pub-id></element-citation></ref>
<ref id="b49-mmr-15-05-3336"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Gasparotto</surname><given-names>D</given-names></name><name><surname>Gloghini</surname><given-names>A</given-names></name><name><surname>Navolanic</surname><given-names>PM</given-names></name><name><surname>De Re</surname><given-names>V</given-names></name><name><surname>Carbone</surname><given-names>A</given-names></name></person-group><article-title>Hepatitis C virus (HCV) I hepatitis C virus (HCV) infection and lymphoproliferative disorders</article-title><source>Front Biosci</source><volume>10</volume><fpage>2460</fpage><lpage>2471</lpage><year>2005</year><pub-id pub-id-type="doi">10.2741/1710</pub-id><pub-id pub-id-type="pmid">15970508</pub-id></element-citation></ref>
<ref id="b50-mmr-15-05-3336"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beggs</surname><given-names>C</given-names></name><name><surname>Knibbs</surname><given-names>LD</given-names></name><name><surname>Johnson</surname><given-names>GR</given-names></name><name><surname>Morawska</surname><given-names>L</given-names></name></person-group><article-title>Environmental contamination and hospital-acquired infection: Factors that are easily overlooked</article-title><source>Indoor Air</source><volume>25</volume><fpage>462</fpage><lpage>474</lpage><year>2015</year><pub-id pub-id-type="doi">10.1111/ina.12170</pub-id><pub-id pub-id-type="pmid">25346039</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-15-05-3336" position="float">
<label>Figure 1.</label>
<caption><p>HCV infection status among HCWs according to the previous experience by Rapisarda <italic>et al</italic>, 2013 (<xref rid="b21-mmr-15-05-3336" ref-type="bibr">21</xref>). (A) Frequency of HCWs with and without HCV infection; (B) Distribution of HCV-infected HCWs according to professional category. HCWs, health care workers; HCV, human hepatitis C.</p></caption>
<graphic xlink:href="MMR-15-05-3336-g00.jpg"/>
</fig>
</floats-group>
</article>
